0001127602-23-013708.txt : 20230428 0001127602-23-013708.hdr.sgml : 20230428 20230428064620 ACCESSION NUMBER: 0001127602-23-013708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230427 FILED AS OF DATE: 20230428 DATE AS OF CHANGE: 20230428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Stan CENTRAL INDEX KEY: 0001913199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 23860041 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0407 4 2023-04-27 0001878313 MAIA Biotechnology, Inc. MAIA 0001913199 Smith Stan 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Common Stock 2023-04-27 4 P 0 133300 2.25 A 686628 I See Footnote These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993. /s/ Stan V. Smith 2023-04-28